Skip to main content
Erschienen in: Journal of Neurology 3/2017

24.01.2017 | Original Communication

Is increased spinal nociception another hallmark for Parkinson’s disease?

verfasst von: Evangelia Boura, Maria Stamelou, David Vadasz, Vincent Ries, Marcus M. Unger, Georg Kägi, Wolfgang H. Oertel, Jens C. Möller, Veit Mylius

Erschienen in: Journal of Neurology | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Augmented spinal nociception during the “off” phase has been observed early in Parkinson’s disease further increasing with disease duration. To find out whether increased spinal nociception represents a premotor feature, experimental pain sensitivity was assessed in idiopathic REM-sleep behavior disorder (IRBD) patients with or without signs of a neurodegenerative disorder compared to early Parkinson’s disease (ePD) patients and healthy controls (HC). Spinal nociception as measured by the nociceptive flexion reflex (NFR) and experimental pain sensitivity as measured by heat and electrical pain thresholds were determined in 14 IRBD, 15 ePD patients in the medication-defined “off” state and 27 HC in an explorative cohort study. No significant differences between IRBD and HC were found with regard to spinal nociception (NFR) and experimental pain sensitivity. However, IRBD patient with anosmia and/or abnormal DaTSCAN tended to increased experimental pain sensitivity. In contrast, early PD patients exhibited increased NFR responses compared to HC, and a tendency for increased spinal nociception compared to IRBD patients. Increased spinal nociception may represent an early but not a premotor, non-motor feature of PD. Whether increased pain sensitivity already presents a premotor feature should be assessed in further studies.
Literatur
1.
Zurück zum Zitat Beiske AG, Loge JH, Ronningen A, Svensson E (2009) Pain in Parkinson’s disease: prevalence and characteristics. Pain 141:173–177CrossRefPubMed Beiske AG, Loge JH, Ronningen A, Svensson E (2009) Pain in Parkinson’s disease: prevalence and characteristics. Pain 141:173–177CrossRefPubMed
2.
Zurück zum Zitat Braak H, Sastre M, Bohl JR, de Vos RA, Del Tredici K (2007) Parkinson’s disease: lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic pre- and postganglionic neurons. Acta Neuropathol 113:421–429CrossRefPubMed Braak H, Sastre M, Bohl JR, de Vos RA, Del Tredici K (2007) Parkinson’s disease: lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic pre- and postganglionic neurons. Acta Neuropathol 113:421–429CrossRefPubMed
3.
Zurück zum Zitat Brefel-Courbon C, Payoux P, Thalamas C, Ory F, Quelven I, Chollet F, Montastruc JL, Rascol O (2005) Effect of levodopa on pain threshold in Parkinson’s disease: a clinical and positron emission tomography study. Mov Disord 20:1557–1563CrossRefPubMed Brefel-Courbon C, Payoux P, Thalamas C, Ory F, Quelven I, Chollet F, Montastruc JL, Rascol O (2005) Effect of levodopa on pain threshold in Parkinson’s disease: a clinical and positron emission tomography study. Mov Disord 20:1557–1563CrossRefPubMed
4.
Zurück zum Zitat Chaudhuri KR, Schapira AH (2009) Non-motor symptoms of Parkinson’s disease: dopaminergic pathophysiology and treatment. Lancet Neurol 8:464–474CrossRefPubMed Chaudhuri KR, Schapira AH (2009) Non-motor symptoms of Parkinson’s disease: dopaminergic pathophysiology and treatment. Lancet Neurol 8:464–474CrossRefPubMed
5.
Zurück zum Zitat Claassen DO, Josephs KA, Ahlskog JE, Silber MH, Tippmann-Peikert M, Boeve BF (2010) REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century. Neurology 75:494–499CrossRefPubMedPubMedCentral Claassen DO, Josephs KA, Ahlskog JE, Silber MH, Tippmann-Peikert M, Boeve BF (2010) REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century. Neurology 75:494–499CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Defazio G, Berardelli A, Fabbrini G, Martino D, Fincati E, Fiaschi A, Moretto G, Abbruzzese G, Marchese R, Bonuccelli U, Del Dotto P, Barone P, De Vivo E, Albanese A, Antonini A, Canesi M, Lopiano L, Zibetti M, Nappi G, Martignoni E, Lamberti P, Tinazzi M (2008) Pain as a nonmotor symptom of Parkinson disease: evidence from a case-control study. Arch Neurol 65:1191–1194CrossRefPubMed Defazio G, Berardelli A, Fabbrini G, Martino D, Fincati E, Fiaschi A, Moretto G, Abbruzzese G, Marchese R, Bonuccelli U, Del Dotto P, Barone P, De Vivo E, Albanese A, Antonini A, Canesi M, Lopiano L, Zibetti M, Nappi G, Martignoni E, Lamberti P, Tinazzi M (2008) Pain as a nonmotor symptom of Parkinson disease: evidence from a case-control study. Arch Neurol 65:1191–1194CrossRefPubMed
7.
Zurück zum Zitat Djaldetti R, Shifrin A, Rogowski Z, Sprecher E, Melamed E, Yarnitsky D (2004) Quantitative measurement of pain sensation in patients with Parkinson disease. Neurology 62:2171–2175CrossRefPubMed Djaldetti R, Shifrin A, Rogowski Z, Sprecher E, Melamed E, Yarnitsky D (2004) Quantitative measurement of pain sensation in patients with Parkinson disease. Neurology 62:2171–2175CrossRefPubMed
8.
Zurück zum Zitat Duchna HW (2006) Sleep-related breathing disorders—a second edition of the international classification of sleep disorders (ICSD-2) of the American Academy of Sleep Medicine (AASM). Pneumologie 60:568–575CrossRefPubMed Duchna HW (2006) Sleep-related breathing disorders—a second edition of the international classification of sleep disorders (ICSD-2) of the American Academy of Sleep Medicine (AASM). Pneumologie 60:568–575CrossRefPubMed
10.
Zurück zum Zitat Gaenslen A, Wurster I, Brockmann K, Huber H, Godau J, Faust B, Lerche S, Eschweiler GW, Maetzler W, Berg D (2014) Prodromal features for Parkinson’s disease—baseline data from the TREND study. Eur J Neurol 21:766–772CrossRefPubMed Gaenslen A, Wurster I, Brockmann K, Huber H, Godau J, Faust B, Lerche S, Eschweiler GW, Maetzler W, Berg D (2014) Prodromal features for Parkinson’s disease—baseline data from the TREND study. Eur J Neurol 21:766–772CrossRefPubMed
11.
Zurück zum Zitat Gagnon JF, Vendette M, Postuma RB, Desjardins C, Massicotte-Marquez J, Panisset M, Montplaisir J (2009) Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson’s disease. Ann Neurol 66:39–47CrossRefPubMed Gagnon JF, Vendette M, Postuma RB, Desjardins C, Massicotte-Marquez J, Panisset M, Montplaisir J (2009) Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson’s disease. Ann Neurol 66:39–47CrossRefPubMed
12.
Zurück zum Zitat Gerdelat-Mas A, Simonetta-Moreau M, Thalamas C, Ory-Magne F, Slaoui T, Rascol O, Brefel-Courbon C (2007) Levodopa raises objective pain threshold in Parkinson’s disease: a RIII reflex study. J Neurol Neurosurg Psychiatry 78:1140–1142CrossRefPubMedPubMedCentral Gerdelat-Mas A, Simonetta-Moreau M, Thalamas C, Ory-Magne F, Slaoui T, Rascol O, Brefel-Courbon C (2007) Levodopa raises objective pain threshold in Parkinson’s disease: a RIII reflex study. J Neurol Neurosurg Psychiatry 78:1140–1142CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Geroin C, Gandolfi M, Bruno V, Smania N, Tinazzi M (2016) Integrated approach for pain management in Parkinson disease. Curr Neurol Neurosci Rep 16:28CrossRefPubMed Geroin C, Gandolfi M, Bruno V, Smania N, Tinazzi M (2016) Integrated approach for pain management in Parkinson disease. Curr Neurol Neurosci Rep 16:28CrossRefPubMed
14.
Zurück zum Zitat Gibb WR, Lees AJ (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry 51:745–752CrossRefPubMedPubMedCentral Gibb WR, Lees AJ (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry 51:745–752CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Hakki Onen S, Alloui A, Jourdan D, Eschalier A, Dubray C (2001) Effects of rapid eye movement (REM) sleep deprivation on pain sensitivity in the rat. Brain Res 900:261–267CrossRefPubMed Hakki Onen S, Alloui A, Jourdan D, Eschalier A, Dubray C (2001) Effects of rapid eye movement (REM) sleep deprivation on pain sensitivity in the rat. Brain Res 900:261–267CrossRefPubMed
16.
Zurück zum Zitat Holtbernd F, Gagnon JF, Postuma RB, Ma Y, Tang CC, Feigin A, Dhawan V, Vendette M, Soucy JP, Eidelberg D, Montplaisir J (2014) Abnormal metabolic network activity in REM sleep behavior disorder. Neurology 82:620–627CrossRefPubMedPubMedCentral Holtbernd F, Gagnon JF, Postuma RB, Ma Y, Tang CC, Feigin A, Dhawan V, Vendette M, Soucy JP, Eidelberg D, Montplaisir J (2014) Abnormal metabolic network activity in REM sleep behavior disorder. Neurology 82:620–627CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Hummel T, Kobal G, Gudziol H, Mackay-Sim A (2007) Normative data for the “Sniffin’ Sticks” including tests of odor identification, odor discrimination, and olfactory thresholds: an upgrade based on a group of more than 3,000 subjects. Eur Arch Otorhinolaryngol 264:237–243CrossRefPubMed Hummel T, Kobal G, Gudziol H, Mackay-Sim A (2007) Normative data for the “Sniffin’ Sticks” including tests of odor identification, odor discrimination, and olfactory thresholds: an upgrade based on a group of more than 3,000 subjects. Eur Arch Otorhinolaryngol 264:237–243CrossRefPubMed
18.
Zurück zum Zitat Iranzo A, Santamaria J, Tolosa E (2016) Idiopathic rapid eye movement sleep behaviour disorder: diagnosis, management, and the need for neuroprotective interventions. Lancet Neurol 15:405–419CrossRefPubMed Iranzo A, Santamaria J, Tolosa E (2016) Idiopathic rapid eye movement sleep behaviour disorder: diagnosis, management, and the need for neuroprotective interventions. Lancet Neurol 15:405–419CrossRefPubMed
19.
Zurück zum Zitat Iranzo A, Valldeoriola F, Lomena F, Molinuevo JL, Serradell M, Salamero M, Cot A, Ros D, Pavia J, Santamaria J, Tolosa E (2011) Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study. Lancet Neurol 10:797–805CrossRefPubMed Iranzo A, Valldeoriola F, Lomena F, Molinuevo JL, Serradell M, Salamero M, Cot A, Ros D, Pavia J, Santamaria J, Tolosa E (2011) Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study. Lancet Neurol 10:797–805CrossRefPubMed
20.
Zurück zum Zitat Kunz M, Mylius V, Scharmann S, Schepelman K, Lautenbacher S (2009) Influence of dementia on multiple components of pain. Eur J Pain 13:317–325CrossRefPubMed Kunz M, Mylius V, Scharmann S, Schepelman K, Lautenbacher S (2009) Influence of dementia on multiple components of pain. Eur J Pain 13:317–325CrossRefPubMed
21.
Zurück zum Zitat Lautenbacher S, Kundermann B, Krieg JC (2006) Sleep deprivation and pain perception. Sleep Med Rev 10:357–369CrossRefPubMed Lautenbacher S, Kundermann B, Krieg JC (2006) Sleep deprivation and pain perception. Sleep Med Rev 10:357–369CrossRefPubMed
22.
Zurück zum Zitat Lee MA, Walker RW, Hildreth TJ, Prentice WM (2006) A survey of pain in idiopathic Parkinson’s disease. J Pain Symptom Manag 32:462–469CrossRef Lee MA, Walker RW, Hildreth TJ, Prentice WM (2006) A survey of pain in idiopathic Parkinson’s disease. J Pain Symptom Manag 32:462–469CrossRef
23.
Zurück zum Zitat Lin CH, Wu RM, Chang HY, Chiang YT, Lin HH (2013) Preceding pain symptoms and Parkinson’s disease: a nationwide population-based cohort study. Eur J Neurol 20:1398–1404CrossRefPubMed Lin CH, Wu RM, Chang HY, Chiang YT, Lin HH (2013) Preceding pain symptoms and Parkinson’s disease: a nationwide population-based cohort study. Eur J Neurol 20:1398–1404CrossRefPubMed
24.
Zurück zum Zitat Mylius V, Brebbermann J, Dohmann H, Engau I, Oertel WH, Möller JC (2011) Pain sensitivity and clinical progression in Parkinson’s disease. Mov Disord 26:2220–2225CrossRefPubMed Mylius V, Brebbermann J, Dohmann H, Engau I, Oertel WH, Möller JC (2011) Pain sensitivity and clinical progression in Parkinson’s disease. Mov Disord 26:2220–2225CrossRefPubMed
25.
Zurück zum Zitat Mylius V, Ciampi de Andrade D, Cury RG, Teepker M, Ehrt U, Eggert KM, Beer SM, Kesselring J, Stamelou M, Möller JC, Oertel WH, Lefaucheur JP (2015) Pain in Parkinson disease: current concepts and a new diagnostic algorithm. Mov Disord Clin Pract 2:357–364CrossRef Mylius V, Ciampi de Andrade D, Cury RG, Teepker M, Ehrt U, Eggert KM, Beer SM, Kesselring J, Stamelou M, Möller JC, Oertel WH, Lefaucheur JP (2015) Pain in Parkinson disease: current concepts and a new diagnostic algorithm. Mov Disord Clin Pract 2:357–364CrossRef
26.
Zurück zum Zitat Mylius V, Engau I, Teepker M, Stiasny-Kolster K, Schepelmann K, Oertel WH, Lautenbacher S, Möller JC (2009) Pain sensitivity and descending inhibition of pain in Parkinson’s disease. J Neurol Neurosurg Psychiatry 80:24–28CrossRefPubMed Mylius V, Engau I, Teepker M, Stiasny-Kolster K, Schepelmann K, Oertel WH, Lautenbacher S, Möller JC (2009) Pain sensitivity and descending inhibition of pain in Parkinson’s disease. J Neurol Neurosurg Psychiatry 80:24–28CrossRefPubMed
27.
Zurück zum Zitat Mylius V, Kunz M, Hennighausen E, Lautenbacher S, Schepelmann K (2008) Effects of ageing on spinal motor and autonomic pain responses. Neurosci Lett 446:129–132CrossRefPubMed Mylius V, Kunz M, Hennighausen E, Lautenbacher S, Schepelmann K (2008) Effects of ageing on spinal motor and autonomic pain responses. Neurosci Lett 446:129–132CrossRefPubMed
28.
Zurück zum Zitat Mylius V, Pee S, Pape H, Teepker M, Stamelou M, Eggert K, Lefaucheur JP, Oertel WH, Möller JC (2016) Experimental pain sensitivity in multiple system atrophy and Parkinson’s disease at an early stage. Eur J Pain 20:1223–1228CrossRefPubMed Mylius V, Pee S, Pape H, Teepker M, Stamelou M, Eggert K, Lefaucheur JP, Oertel WH, Möller JC (2016) Experimental pain sensitivity in multiple system atrophy and Parkinson’s disease at an early stage. Eur J Pain 20:1223–1228CrossRefPubMed
30.
Zurück zum Zitat Postuma RB, Gagnon JF, Montplaisir J (2008) Autonomic dysfunction in RBD—what can it teach us about disease progression? Sleep Med 9:473–474CrossRefPubMed Postuma RB, Gagnon JF, Montplaisir J (2008) Autonomic dysfunction in RBD—what can it teach us about disease progression? Sleep Med 9:473–474CrossRefPubMed
31.
Zurück zum Zitat Schenck CH, Bundlie SR, Patterson AL, Mahowald MW (1987) Rapid eye movement sleep behavior disorder. A treatable parasomnia affecting older adults. JAMA 257:1786–1789CrossRefPubMed Schenck CH, Bundlie SR, Patterson AL, Mahowald MW (1987) Rapid eye movement sleep behavior disorder. A treatable parasomnia affecting older adults. JAMA 257:1786–1789CrossRefPubMed
32.
Zurück zum Zitat Schenck CH, Mahowald MW (2002) REM sleep behavior disorder: clinical, developmental, and neuroscience perspectives 16 years after its formal identification in SLEEP. Sleep 25:120–138PubMed Schenck CH, Mahowald MW (2002) REM sleep behavior disorder: clinical, developmental, and neuroscience perspectives 16 years after its formal identification in SLEEP. Sleep 25:120–138PubMed
33.
Zurück zum Zitat Schrag A, Horsfall L, Walters K, Noyce A, Petersen I (2015) Prediagnostic presentations of Parkinson’s disease in primary care: a case-control study. Lancet Neurol 14:57–64CrossRefPubMed Schrag A, Horsfall L, Walters K, Noyce A, Petersen I (2015) Prediagnostic presentations of Parkinson’s disease in primary care: a case-control study. Lancet Neurol 14:57–64CrossRefPubMed
34.
Zurück zum Zitat Stamelou M, Dohmann H, Brebermann J, Boura E, Oertel WH, Höglinger G, Möller JC, Mylius V (2012) Clinical pain and experimental pain sensitivity in progressive supranuclear palsy. Parkinsonism Relat Disord 18:606–608CrossRefPubMed Stamelou M, Dohmann H, Brebermann J, Boura E, Oertel WH, Höglinger G, Möller JC, Mylius V (2012) Clinical pain and experimental pain sensitivity in progressive supranuclear palsy. Parkinsonism Relat Disord 18:606–608CrossRefPubMed
35.
Zurück zum Zitat Stiasny-Kolster K, Doerr Y, Möller JC, Hoffken H, Behr TM, Oertel WH, Mayer G (2005) Combination of ‘idiopathic’ REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT. Brain 128:126–137CrossRefPubMed Stiasny-Kolster K, Doerr Y, Möller JC, Hoffken H, Behr TM, Oertel WH, Mayer G (2005) Combination of ‘idiopathic’ REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT. Brain 128:126–137CrossRefPubMed
36.
Zurück zum Zitat Storch A, Schneider CB, Wolz M, Sturwald Y, Nebe A, Odin P, Mahler A, Fuchs G, Jost WH, Chaudhuri KR, Koch R, Reichmann H, Ebersbach G (2013) Nonmotor fluctuations in Parkinson disease: severity and correlation with motor complications. Neurology 80:800–809CrossRefPubMed Storch A, Schneider CB, Wolz M, Sturwald Y, Nebe A, Odin P, Mahler A, Fuchs G, Jost WH, Chaudhuri KR, Koch R, Reichmann H, Ebersbach G (2013) Nonmotor fluctuations in Parkinson disease: severity and correlation with motor complications. Neurology 80:800–809CrossRefPubMed
37.
Zurück zum Zitat Tinazzi M, Del Vesco C, Fincati E, Ottaviani S, Smania N, Moretto G, Fiaschi A, Martino D, Defazio G (2006) Pain and motor complications in Parkinson’s disease. J Neurol Neurosurg Psychiatry 77:822–825CrossRefPubMedPubMedCentral Tinazzi M, Del Vesco C, Fincati E, Ottaviani S, Smania N, Moretto G, Fiaschi A, Martino D, Defazio G (2006) Pain and motor complications in Parkinson’s disease. J Neurol Neurosurg Psychiatry 77:822–825CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Unger MM, Belke M, Menzler K, Heverhagen JT, Keil B, Stiasny-Kolster K, Rosenow F, Diederich NJ, Mayer G, Möller JC, Oertel WH, Knake S (2010) Diffusion tensor imaging in idiopathic REM sleep behavior disorder reveals microstructural changes in the brainstem, substantia nigra, olfactory region, and other brain regions. Sleep 33:767–773PubMedPubMedCentral Unger MM, Belke M, Menzler K, Heverhagen JT, Keil B, Stiasny-Kolster K, Rosenow F, Diederich NJ, Mayer G, Möller JC, Oertel WH, Knake S (2010) Diffusion tensor imaging in idiopathic REM sleep behavior disorder reveals microstructural changes in the brainstem, substantia nigra, olfactory region, and other brain regions. Sleep 33:767–773PubMedPubMedCentral
39.
Zurück zum Zitat Unger MM, Möller JC, Mankel K, Schmittinger K, Eggert KM, Stamelou M, Stiasny-Kolster K, Bohne K, Bodden M, Mayer G, Oertel WH, Tebbe JJ (2011) Patients with idiopathic rapid-eye-movement sleep behavior disorder show normal gastric motility assessed by the (13) C-octanoate breath test. Mov Disord 26:2559–2563CrossRefPubMed Unger MM, Möller JC, Mankel K, Schmittinger K, Eggert KM, Stamelou M, Stiasny-Kolster K, Bohne K, Bodden M, Mayer G, Oertel WH, Tebbe JJ (2011) Patients with idiopathic rapid-eye-movement sleep behavior disorder show normal gastric motility assessed by the (13) C-octanoate breath test. Mov Disord 26:2559–2563CrossRefPubMed
Metadaten
Titel
Is increased spinal nociception another hallmark for Parkinson’s disease?
verfasst von
Evangelia Boura
Maria Stamelou
David Vadasz
Vincent Ries
Marcus M. Unger
Georg Kägi
Wolfgang H. Oertel
Jens C. Möller
Veit Mylius
Publikationsdatum
24.01.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 3/2017
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-016-8390-y

Weitere Artikel der Ausgabe 3/2017

Journal of Neurology 3/2017 Zur Ausgabe

Pioneers in Neurology

Edwin Bickerstaff (1920–2008)

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.